Please assess the completion status of the following clinical trial:

Trial Title: Eosinophilic Esophagitis Clinical Therapy Comparison Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~1. Signed written informed consent and assent if applicable prior to performing any study specific procedure.~2. Male or female subjects aged 3-17 years old.~3. Diagnosis of EoE within 2 months of enrollment (greater than or equal to 15 eosinophils per high powered field in both proximal or distal esophageal specimens).~4. Subjects who have failed at least a two month trial of proton pump inhibitor.~5. A female subject of childbearing potential who is or may become sexually active agrees to routinely use contraception from the time of signing informed consent and assent until 30 days from end of study.~6. Positive allergy testing on prick and/or patch testing.~Exclusion Criteria~1. Subjects who are responsive to at least a two month trial of a proton pump inhibitor.~2. Diagnosis of Inflammatory Bowel Disease or static encephalopathy.~3. Prior abdominal surgery and other organ disorder not including atopic diseases.~4. Previous esophageal surgical procedure.~5. Previous esophageal congenital disorders such as tracheal esophageal fistula and esophageal atresia.~6. Positive for pregnancy.~7. Previous therapy within 6 weeks with oral or swallowed steroids or strict dietary elimination of major allergens~8. Presence of increased eosinophils in the stomach, small intestine, large intestine, and colon based on Debrosse et al.

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Positive for food allergy: Group A (Type: ACTIVE_COMPARATOR): Oral Budesonide
- Positive for food allergy: Group B (Type: ACTIVE_COMPARATOR): Elimination diet

Based on this trial design, predict the completion outcome and termination type (if applicable).